K

Kannarr Eye Care | Kannarr Eye Care - Pittsburg, KS

Research site
(Unclaimed)
Location
2521 N Broadway, Pittsburg, Kansas, United States of America

Site insights

Top conditions

Top treatments

AGN-190584
Omega 3 fatty acid
Povidone
PVP
Latanoprost
Tavilermide
Pilocarpine HCl
TP-03
Clobetasol Propionate
Iodine

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 56 total trials

Control of Myopia Using Novel Spectacle Lens Designs (CYPRESS)

Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and e...

Active, not recruiting
Juvenile Myopia
Device: Novel spectacle lens design
Device: Spectacle lenses

This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficac...

Active, not recruiting
Myopia
Juvenile Myopia
Device: Novel spectacle lens design
Device: Spectacle lenses

This is a conventional efficacy trial to validate the results from previous clinical trials for younger children; the 12-month efficacy results will...

Enrolling
Myopia
Myopia Progression
Device: Single vision, impact-resistant spectacle lenses; Test Arm
Device: Single vision, impact-resistant spectacle lenses; Control Arm

This is a multi-site, bilateral, dispensing, non-randomized, uncontrolled, unmasked, single arm study to evaluate visual acuity in neophytes.

Enrolling
Visual Acuity
Device: ACUVUE OASYS® 1-DAY with HydraLuxe™ TECHNOLOGY (AO1D)
Status recently updated

This will be an open-label, 3-visit, single-arm, dispensing clinical trial to evaluate visual acuity.

Enrolling
Active, not recruiting
Visual Acuity
Device: JJVC Investigational Multifocal Toric Contact Lens manufactured in Senofilcon A (C3) material with UV blocker / HEV filter

The purpose of this post-approval study is to confirm the effectiveness of the MiSight 1 Day lens in clinical practices within the US and to assess t...

Enrolling
Myopia
Device: Proclear 1 day
Device: MiSight 1 Day

To quantify myopic progression (cycloplegic spherical equivalent refraction - cSER) following the cessation of use of specific spectacle lenses.To qu...

Active, not recruiting
Myopia
Myopia Progression
Device: Spectacle Lenses

The goal of this study is to compare the performance of two daily disposable silicone hydrogel lenses.

Enrolling
Myopia
Device: Control Contact Lens (stenfilcon A)
Device: Test Contact Lens (senofilcon A)

The purpose of this study is to evaluate and demonstrate the efficacy and safety of an investigational ocular lubricant formulation in patients with...

Begins enrollment in 1 month
Dry Eye Disease
Other: FID123300 ocular lubricant

Determine if Total30 for Astigmatism contact lenses (CLs) provide a comfortable wearing experience all day. CL discomfort affects most CL wearers wit...

Enrolling
Refractive Errors
Astigmatism
Device: TOTAL30 for Astigmatism Contact Lenses

Trial sponsors

Johnson & Johnson (J&J) logo
CooperVision logo
Alcon logo
S
Allergan logo
Shire logo
AbbVie logo
A
E
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems